The human gut bacterial genotoxin colibactin alkylates DNA.
Matthew R WilsonYindi JiangPeter W VillaltaAlessia StornettaPaul Davis BoudreauAndrea CarráCaitlin A BrennanEunyoung ChunLizzie NgoLeona D SamsonBevin P EngelwardWendy S GarrettSilvia BalboEmily P BalskusPublished in: Science (New York, N.Y.) (2019)
Certain Escherichia coli strains residing in the human gut produce colibactin, a small-molecule genotoxin implicated in colorectal cancer pathogenesis. However, colibactin's chemical structure and the molecular mechanism underlying its genotoxic effects have remained unknown for more than a decade. Here we combine an untargeted DNA adductomics approach with chemical synthesis to identify and characterize a covalent DNA modification from human cell lines treated with colibactin-producing E. coli Our data establish that colibactin alkylates DNA with an unusual electrophilic cyclopropane. We show that this metabolite is formed in mice colonized by colibactin-producing E. coli and is likely derived from an initially formed, unstable colibactin-DNA adduct. Our findings reveal a potential biomarker for colibactin exposure and provide mechanistic insights into how a gut microbe may contribute to colorectal carcinogenesis.
Keyphrases
- escherichia coli
- circulating tumor
- endothelial cells
- cell free
- single molecule
- small molecule
- induced pluripotent stem cells
- pluripotent stem cells
- nucleic acid
- mass spectrometry
- circulating tumor cells
- gene expression
- adipose tissue
- pseudomonas aeruginosa
- metabolic syndrome
- type diabetes
- cystic fibrosis
- staphylococcus aureus
- multidrug resistant
- klebsiella pneumoniae
- gas chromatography mass spectrometry
- artificial intelligence